The phosphoprotein genes of measles viruses from subacute sclerosing panencephalitis cases encode functional as well as non-functional proteins and display reduced editing

Virus Research

Volumn 211, Issue , 2016, Pages 29-37

  Millar, E L ^a   Rennick, L J ^a,b   Weissbrich, B ^c   Schneider Schaulies, J ^c   Duprex, W P ^a,b   Rima, B K ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Absence of biased hypermutation; Editing; Genetic variation; Measles virus; Phosphoprotein gene; Subacute sclerosing panencephalitis

Indexed keywords

GUANINE; MESSENGER RNA; NUCLEOTIDE; PHOSPHOPROTEIN; PROTEIN DERIVATIVE; VIRUS PROTEIN V; VIRAL PROTEIN;

ARTICLE; CHILD; FEMALE; GENE INSERTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALE; MEASLES VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION; GENETICS; INFANT; ISOLATION AND PURIFICATION; METABOLISM; MUTATION; PRESCHOOL CHILD; RNA EDITING; VIROLOGY;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MEASLES VIRUS; MUTATION; PHOSPHOPROTEINS; RNA EDITING; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRAL PROTEINS;

EID: 84951840492     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.09.016     Document Type: Article

References (49)

1. Allmendinger A., Doege C., Wolf N., Brückner H., Stippich C., Weißrich B., Roeber S., Parthe-Peterhans S., Ebinger F. Subakut sklerosierende panenzephalitis nach masern-exposition im süuglingsalter. Monatsschr. Kinderheilk. 2009, 157:55-60.
2. Baczko K., Carter M.J., Billeter M., ter Meulen V. Measles virus gene expression in subacuate sclerosing panencephalitis. Virus Res. 1984, 1(7):585-595.
3. Baczko K., Pardowitz I., Rima B.K., ter Meulen V. Constant and variable regions of measles virus proteins encoded by the nucleocapsid and phosphoprotein genes derived from lytic and persistent viruses. Virology 1992, 190:469-474.
4. Baczko K., Lampe J., Liebert U.G., Brinckmann U., ter Meulen V., Pardowitz I., Budka H., Cosby S.L., Isserte S., Rima B.K. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 1993, 197:188-195.
5. Bankamp B., Lopareva E.N., Kremer J.R., Tian Y., Clemens M.S., Patel R., Fowlkes A.L., Kessler J.R., Muller C.P., Bellini W.J., Rota P.A. Genetic variability and mRNA editing frequencies of the phosphoprotein genes of wild-type measles viruses. Virus Res. 2008, 135:298-306.
6. Bellini W.J., Rota J.S., Rota P.A. Virology of measles virus. J. Infect. Dis. 1994, 170(Suppl):S15-S23.
7. Bellini W.J., Rota J.S., Lowe L.E., Katz R.S., Dyken P.R., Zaki S.R., Shieh W.J., Rota P.A. Subacute sclerosing panencephalitis: more cases of this fatal disease are preveneted by measles immunization than was previously recognized. J. Infect. Dis. 2005, 192(100):1686-1693.
8. Brown D.D., Collins F.M., Duprex W.P., Baron M.D., Barrett T., Rima B.K. Rescue of mini-genomic constructs and viruses by combinations of morbillivirus N, P and L proteins. J. Gen. Virol. 2005, 86:1077-1081.
9. Burgoon M.P., Owens G.P., Smith-Jensen T., Walker D., Gilden D.H. Cloning the antibody response in humans with inflammatory central nervous system disease: analysis of the expressed IgG repertoire in subacute sclerosing panencephalitis brain reveals disease-relevant antibodies that recognize specific measles virus antigens. J. Immunol. 1999, 163:3496-3502.
10. Cattaneo R., Billeter M.A. Mutations and A/I hypermutations in measles virus persistent infections. Curr. Top. Microbiol. Immunol. 1992, 176:63-74.
11. Cattaneo R., Rose J.K. Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J. Virol. 1993, 67:1493-1502.
12. Cattaneo R., Rebmann G., Schmid A., Baczko K., Ter V.M., Billeter M.A., Ter Meulen V. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 1987, 6:681-688.
13. Cattaneo R., Schmid A., Billeter M.A., Sheppard R.D., Udem S.A. Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J. Virol. 1988, 62:1388-1397.
14. Cattaneo R., Kaelin K., Baczko K., Billeter M.A. Measles virus editing provides an additional cysteine-rich protein. Cell 1989, 56:759-764.
15. Cattaneo R., Schmid A., Spielhofer P., Kaelin K., Baczko K., ter V.M., Pardowitz J., Flanagan S., Rima B.K., Udem S.A. Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology 1989, 173:415-425.
16. Coughlan S., Connell J., Cohen B., Jin L., Hall W.W. Suboptimal measles-mumps-rubella vaccination coverage facilitates an imported measles outbreak in ireland. Clin. Infect. Dis. 2002, 35:84-86.
17. Devaux P., Cattaneo R. Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J. Virol. 2004, 78:11632-11640.
18. Devaux P., von Messling V., Songsungthong W., Springfeld C., Cattaneo R. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 2007, 360:72-83.
19. El Mubarak H.S., Yüksel S., Van Amerongen G., Mulder P.G., Mukhtar M.M., Osterhaus A.D., de Swart R.L. Infection of cynomolgus macaques (Macaca fascicularis) and rhesusmacaques (Macaca mulatta) with different wild-type measles viruses. J. Gen. Virol. 2007, 88:2028-2034.
20. Escoffier C., Manie S., Vincent S., Muller C.P., Billeter M., Gerlier D. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J. Virol. 1999, 73:1695-1698.
21. Perry R.T., Gacic-Dobo M., Dabbagh A., Mukders M.N., Strebel P.M., Okwo-bele J.M., Rota P.A., Goodson J.L. Global control and regional elimination of measles, 2000-2012. MMWR. Morb. Mortal. Wkly. Rep. 2014, 63:103-107.
22. Hirano A. Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence. J. Virol. 1992, 66:1891-1898.
23. Horikami S.M., Moyer S.A. Synthesis of leader RNA and editing of the P mRNA during transcription by purified measles virus. J. Virol. 1991, 65:5342-5347.
24. Jin L., Beard S., Hunjan R., Brown D.W., Miller E. Characterization of measles virus strains causing SSPE: a study of 11 cases. J. Neurovirol. 2002, 8:335-344.
25. Komase K., Rima B.K., Pardowitz I., Kunz C., Billeter M.A., ter Meulen V., Baczko K. A comparison of nucleotide sequences of measles virus L genes derived from wild-type viruses and SSPE brain tissues. Virology 1995, 208:795-799.
26. Kulkarni S., Volchkova V., Basler C.F., Palese P., Volchkov V.E., Shaw M.L. Nipah virus edits its P gene at high frequency to express the V and W proteins. J. Virol. 2009, 83:3982-3987.
27. Liebert U.G., Baczko K., Budka H., ter Meulen V. Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J. Gen. Virol. 1986, 67:2435-2444.
28. Liljeroos L., Huiskonen J.T., Ora A., Susi P., Butcher S.J. Electron cryotomography of measles virus reveals how matrix protein coats the ribonucleocapsid within intact virions. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18085-18090.
29. Liston P., Briedis D.J. Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein. J. Virol. 1995, 69:6742-6750.
30. Ludlow M., McQuaid S., Cosby S.L., Cattaneo R., Rima B.K., Duprex W.P. Measles virus superinfection immunity and receptor redistribution in persistently infected NT2 cells. J. Gen. Virol. 2005, 86:2291-2303.
31. Mühlebach M.D., Mateo M., Sinn P.L., Prüfer S., Uhlig K.M., Leonard V.H.J., Navaratnarajah C.K., Frenzke M., Wong X.X., Sawatsky B., Ramachandran S., McCray P.B., Cichutek K., von Messling V., Lopez M., Cattaneo R. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011, 480:530-533.
32. Noyce R.S., Bondre D.G., Ha M.N., Lin L.-T., Sisson G., Tsao M.-S., Richardson C.D. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS pathog. 2011, 7:e1002240.
33. Owens G.P., Shearer A.J., Yu X., Ritchie A.M., Keays K.M., Bennett J.L., Gilden D.H., Burgoon M.P. Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein. J. Virol. 2006, 80:12121-12130.
34. Ogura H., Ayata M., Hayashi K., Seto T., Matsuoka O., Hattori H., Tanaka K., Tanaka K., Takano Y.M.R. Efficient isolation of subacute sclerosing panencephalitis virus from patient brains by reference to magnetic resonance and computed tomographic images. J. Neurovirol. 1997, 3:304-309.
35. Ramachandran A., Parisien J.-P., Horvath C.M. STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition. J. Virol. 2008, 82:8330-8338.
36. Rataul S.M., Hirano A., Wong T.C. Irreversible modification of measles virus RNA in vitro by nuclear RNA-unwinding activity in human neuroblastoma cells. J. Virol. 1992, 66:1769-1773.
37. Rennick L.J., Duprex W.P., Rima B.K. Measles virus minigenomes encoding two autofluorescent proteins reveal cell-to-cell variation in reporter expression dependent on viral sequences between the transcription units. J. Gen. Virol. 2007, 88:2710-2718.
38. Reutter G.L., Cortese-Grogan C., Wilson J., Moyer S.A. Mutations in the measles virus C protein that up regulate viral RNA synthesis. Virology 2001, 285:100-109.
39. Rima B.K., Duprex W.P. Molecular mechanisms of measles virus persistence. Virus Res. 2005, 111:132-147.
40. Rima B.K., Duprex W.P. New concepts in measles virus replication: getting in and out in vivo and modulating the host cell environment. Virus Res. 2011, 162:47-62.
41. Rima B.K., Earle J.A., Baczko K., Rota P.A., Bellini W.J. Measles virus strain variations. Curr. Top. Microbiol. Immunol. 1995, 191:65-83.
42. Schmid A., Spielhofer P., Cattaneo R., Baczko K., ter Meulen V., Billeter M.A. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology 1992, 188:910-915.
43. Schneider-Schaulies S., Liebert U.G., Baczko K., Cattaneo R., Billeter M., ter Meulen V. Restriction of measles virus gene expression in acute and subacute encephalitis of Lewis rats. Virology 1989, 171:525-534.
44. Schönberger K., Ludwig M.S., Wildner M., Weissbrich B. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009; a risk estimate. PLoS One 2013, 8(7):e68909.
45. Takeuchi K., Takeda M., Miyajima N., Ami Y., Nagata N., Suzaki Y., Shahnewaz J., Kadota S., Nagata K. Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J. Virol. 2005, 79:7838-7844.
46. Vanchiere J.A., Bellini W.J., Moyer S.A. Hypermutation of the phosphoprotein and altered mRNA editing in the hamster neurotropic strain of measles virus. Virology 1995, 207:555-561.
47. Vidal S., Curran J., Kolakofsky D. A stuttering model for paramyxovirus P mRNA editing. EMBO J. 1990, 9:2017-2022.
48. Vieker S., Schmitt J.J., Behrens C., Weissbrich B., Hartmann H. Subacute sclerosing panencephalitis in two brothers. Neuropediatrics 2003, 34:326-329.
49. Wong T.C., Ayata M., Hirano A., Yoshikawa Y., Tsuruoka H., Yamanouchi K. Generalized and localized biased hypermutation affecting the matrix gene of a measles virus strain that causes subacute sclerosing panencephalitis. J. Virol. 1989, 63:5464-5468.